Cancer immunotherapy has recently gained much attention in the search of cancer cure due
to its ability to “train” the immune system in seeking out and removing residual tumor cells …

Cancer immunotherapy by educating or stimulating patients' own immune systems to attack
cancer cells has demonstrated promising therapeutic responses in the clinic. However …

CD47, overexpressed on kinds of tumor cells, activates a “don't eat me” signal through
binding to signal regulatory protein α (SIRPα), leading to immune escape from the …

A therapeutic strategy that can eliminate primary tumours, inhibit metastases, and prevent
tumour relapses is developed herein by combining adjuvant nanoparticle-based …

Combined phototherapy and immunotherapy demonstrates strong potential in the treatment
of metastatic cancers. An upconversion nanoparticle (UCNP) based antigen‐capturing …

As one of the most serious threats to human being, cancer is hard to be treated when
metastasis happens. What's worse, there are few identified targets of metastasis for drug …

Skin cancers are by far the most common malignancy of humans, particularly in the white
population. The growing incidence of cutaneous malignancies has heralded the need for …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Melanoma focuses on adjuvant therapy and treatment of in-transit disease, because …

Immunosuppressive tumor microenvironments (TMEs) create tremendous obstacles for an
effective cancer therapy. Herein, we developed a melittin-RADA32 hybrid peptide hydrogel …

Targeted therapy and immunotherapy in combination is considered the ideal strategy for
treating metastatic cancer, as it can eliminate the primary tumors and induce host immunity …